PL307138A1 - Amyline antagonists and agonists - Google Patents

Amyline antagonists and agonists

Info

Publication number
PL307138A1
PL307138A1 PL94307138A PL30713894A PL307138A1 PL 307138 A1 PL307138 A1 PL 307138A1 PL 94307138 A PL94307138 A PL 94307138A PL 30713894 A PL30713894 A PL 30713894A PL 307138 A1 PL307138 A1 PL 307138A1
Authority
PL
Poland
Prior art keywords
amyline
agonists
antagonists
amyline antagonists
Prior art date
Application number
PL94307138A
Other languages
English (en)
Inventor
Ambikaipakan Balasubramaniam
Original Assignee
Univ Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cincinnati filed Critical Univ Cincinnati
Publication of PL307138A1 publication Critical patent/PL307138A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
PL94307138A 1993-05-12 1994-05-11 Amyline antagonists and agonists PL307138A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6026593A 1993-05-12 1993-05-12

Publications (1)

Publication Number Publication Date
PL307138A1 true PL307138A1 (en) 1995-05-02

Family

ID=22028421

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94307138A PL307138A1 (en) 1993-05-12 1994-05-11 Amyline antagonists and agonists

Country Status (10)

Country Link
EP (1) EP0651651A1 (fr)
JP (1) JPH07509008A (fr)
AU (1) AU669636B2 (fr)
CA (1) CA2139651A1 (fr)
CZ (1) CZ5795A3 (fr)
HU (1) HUT70176A (fr)
PL (1) PL307138A1 (fr)
RU (1) RU95106486A (fr)
WO (1) WO1994026292A1 (fr)
ZA (1) ZA943251B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739106A (en) * 1995-06-07 1998-04-14 Rink; Timothy J. Appetite regulating compositions
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
US6087334A (en) * 1998-08-21 2000-07-11 Amylin Pharmaceuticals, Inc. Anti-diabetic peptides
RU2385878C2 (ru) 2004-02-11 2010-04-10 Амилин Фармасьютикалз, Инк. Пептид, обладающий свойствами амилина (варианты), и его применение (варианты)
US8575091B1 (en) 2012-04-19 2013-11-05 Novo Nordisk A/S Amylin analogues and pharmaceutical compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266561A (en) * 1988-01-11 1993-11-30 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus
US5580953A (en) * 1991-08-14 1996-12-03 Amylin Pharmaceuticals, Inc. Amylin antagonist peptides and uses therefor

Also Published As

Publication number Publication date
AU669636B2 (en) 1996-06-13
AU6910494A (en) 1994-12-12
HUT70176A (en) 1995-09-28
ZA943251B (en) 1995-01-16
EP0651651A1 (fr) 1995-05-10
JPH07509008A (ja) 1995-10-05
CA2139651A1 (fr) 1994-11-24
RU95106486A (ru) 1996-12-27
HU9500079D0 (en) 1995-03-28
CZ5795A3 (en) 1995-11-15
WO1994026292A1 (fr) 1994-11-24

Similar Documents

Publication Publication Date Title
ZA944338B (en) Neuropeptide Y Antagonists and Agonists
EP0723556A4 (fr) Antagonistes de fas et leurs applications
HU9600932D0 (en) In-alkyl-n-arylpyrimidinamines and derivatives thereof
EP1032377A4 (fr) 2-aminoacetamides substitues et leur utilisation
GB9323111D0 (en) Cryosurical probe
GB9309121D0 (en) Substituted acylating agents
SG50426A1 (en) Lhrh antagonists
GB2281830B (en) I/q-modulator and i/q-demodulator
IL104618A (en) Contact rail and adapter
PL307138A1 (en) Amyline antagonists and agonists
ZA907336B (en) Application aid and the use thereof
GB9701374D0 (en) Purinergic agonists and antagonists
IL104472A0 (en) Substituted hexahydro-azepinones and tetrahydro-benzazepinones
GB9311423D0 (en) New use
HK1014195A1 (en) Polyamide composition and the use
GB9316789D0 (en) Visosity probe
GB9311113D0 (en) Probes
GB9501907D0 (en) Allatostatins and their use
GB9216776D0 (en) Composition and use
GB9306456D0 (en) Composition and use
GB9408859D0 (en) Composition and use
GB9315783D0 (en) Ropes and the use thereof
GB9309179D0 (en) New use
GB9303913D0 (en) Compound and use
GB9311223D0 (en) Compounds and use